Trevena Announces Initiation of OLINVYK® Respiratory Physiology Study Including Elderly / Obese Subjects

NEXT STORY
Cyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conference
PREV STORY
The Worldwide Esoteric Testing Industry is Expected to Reach $36.3 Billion by 2026 at a CAGR of 11.6% from 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kura Oncology to Report Second Quarter 2017 Financial Results

LA JOLLA, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a ...

author_avatar
NASDAQ Market News

Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients

Completed Phase 1 trial establishes Oral KORSUVA tablet strengths for treatment of CKD-associated pruritusSTAMFORD, ...

author_avatar
NASDAQ Market News

Celsion Corporation Reports Third Quarter 2016 Financial Results and Provides Business Update

Meaningful Progress with the ThermoDox® OPTIMA Study and GEN-1 Immunotherapy Program, Including Highly Encouraging ...

author_avatar
NASDAQ Market News